Franklin Global Quality Dividend UCITS ETF

Investment Objective To provide exposure to medium and large capitalisation companies with high and persistent dividend income in developed and emerging markets globally. Investment Policy The Fund invests in equities of companies of medium and large market capitalisation that are included in the benchmark. These investments may be from anywhere in the world, including emerging markets.The holdings of the Index comprise 100 stocks which are selected from the MSCI ACWI ex REITS Index (Net Return), using a selection process which applies a dividend persistence and yield screen followed by a quality screen.Income from the Fund's investments (if any) will typically be distributed to investors quarterly.Derivatives and techniques The Fund may use derivatives for hedging and efficient portfolio management.Strategy The investment manager seeks to minimise the difference between the Fund's performance and that of the benchmark (tracking error), regardless of whether the benchmark level rises or falls.SFDR category Article 6 (does not promote environmental and/or social characteristics or have a sustainable investment objective under EU regulations).Base currency US dollar (USD).Benchmark(s) LibertyQ Global Dividend Index (Net Return). Used for index tracking only.The Fund is passively managed and seeks to replicate the benchmark by holding all of the Index securities in a similar proportion to their weighting in the benchmark. Its portfolio, and thus its performance, closely resemble that of the benchmark. Share Class Policy Buying and selling shares You may buy or sell shares daily through a broker on the stock exchange where the shares are traded. Authorised participants, such as selected financial institutions, may buy or sell shares directly with the fund, on any day markets are open for business in the United Kingdom (provided that on such day the markets on which substantially all of the Fund's investments are traded are open). For distribution shares, dividend incom

Physical replication

PIR compliant

No

PEA compliant

No

PEA-PME compliant

No